Dyskinesias and
Michael J. Fox
Our doctors discovered, with proper management, the drug packaged with L-dopa is not needed.

Michael_J._FoxAmong Parkinson’s disease patients, 89% take a pill containing two ingredients. One ingredient is L-dopa the most effective treatment known for Parkinson’s disease. The other, a drug that does not improve Parkinson’s disease symptoms. In the past, doctors believed that L-dopa was the primary cause of permanent dyskinesias and choreiform movement disorder which occur during treatment. Our doctors discovered that these movement disorders are caused primarily by a profound nutritional deficiency induced by the drug combined with L-dopa. This drug has no impact on Parkinson’s disease symptoms. Our doctors discovered, with proper management, the drug packaged with L-dopa is not needed.

Watch the Michael J. Fox video found on this page. He is suffering from drug-induced dyskinesias. Mr. Fox is constantly moving. His head is bobbing around. Parkinson’s disease is not the cause of Mr. Fox’s gross movement disorder. His drugs are. 

With the millions of dollars the doctors at the Michael J. Fox Foundation have spent, they never discovered the following basic premise of life. Drugs cannot treat nutritional deficiencies. After the diagnosis of permanent brain damage due to Parkinson’s disease occurs, the nutritional deficiency status drives the intensity of Parkinson’s disease symptoms and drug side effects. The doctors of Mr. Fox have turned him into a poster child with the caption, “Look what my doctors did to me now with the drugs.” Our doctors have found the effective solution for dealing with these dyskinesias and choreiform movement disorder patients.

For more information on your approach to Parkinson’s disease send an email to info@parkinsonsclinics.com or call +01-218-626-2220 (877-626-2220). After you send your email, we may ask for more information. All communications will be kept confidential. If you have any questions, please call us free of charge.

Would you like more information on our unique approach to Parkinson's disease care?